209 related articles for article (PubMed ID: 8134728)
21. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
[TBL] [Abstract][Full Text] [Related]
22. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology.
Barbui T; Finazzi G; Remuzzi A
Thromb Haemost; 1995 Jul; 74(1):511-4. PubMed ID: 8578515
[TBL] [Abstract][Full Text] [Related]
23. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
Kitchen S; Preston FE
Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
[TBL] [Abstract][Full Text] [Related]
24. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
25. [Monitoring for oral anticoagulant therapy].
Nakagawa K; Nakahara Y; Tsuji H
Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
Adcock DM; Johnston M
Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
[TBL] [Abstract][Full Text] [Related]
27. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
[TBL] [Abstract][Full Text] [Related]
28. [Patient self-monitoring of oral anticoagulation with CoaguChek].
Caliezi C; Waber M; Pfiffner D; Saner H; Lämmle B; Wuillemin WA
Schweiz Med Wochenschr; 2000 Jun; 130(24):916-23. PubMed ID: 10909717
[TBL] [Abstract][Full Text] [Related]
29. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
30. "Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study.
Cafolla A; Melizzi R; Baldacci E; Pignoloni P; Dragoni F; Campanelli M; Caraccini R; Foà R
Thromb Res; 2011 Oct; 128(4):325-30. PubMed ID: 21600633
[TBL] [Abstract][Full Text] [Related]
31. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
32. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
33. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
34. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Tripodi A; Breukink-Engbers WG; van den Besselaar AM
Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between prothrombin time international normalized ratio and thrombo test (%)].
Numata Y; Ogata Y; Arao K; Mizumasa Y; Wakita T; Haruguchi H; Araki H; Tsuji T; Mawatari K; Shimada K
J Cardiol; 2001 Dec; 38(6):327-35. PubMed ID: 11806090
[TBL] [Abstract][Full Text] [Related]
37. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
38. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-.
Mori T; Asano M; Ohtake H; Bitoh A; Sekiguchi S; Matsuo Y; Aiba M; Yamada M; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):83-7. PubMed ID: 12027793
[TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
40. INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation.
Hentrich DP; Fritschi J; Müller PR; Wuillemin WA
Thromb Res; 2007; 119(4):489-95. PubMed ID: 16765423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
